Aloha Medicinals
Aloha Medicinals, a leading name in the biotechnology sector, is headquartered in the United States, with significant operations across North America and beyond. Founded in 2000, the company has established itself as a pioneer in the cultivation and production of medicinal mushrooms, focusing on high-quality mycelium and fruiting body extracts. Aloha Medicinals is renowned for its unique, scientifically-backed products that cater to the health and wellness market, including dietary supplements and functional foods. Their commitment to sustainability and innovation has positioned them as a trusted supplier in the industry, achieving notable milestones such as partnerships with major health brands. With a strong emphasis on research and development, Aloha Medicinals continues to lead the way in harnessing the therapeutic potential of mushrooms, setting a benchmark for quality and efficacy in the market.
DitchCarbon Score
How does Aloha Medicinals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aloha Medicinals's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aloha Medicinals's reported carbon emissions
Aloha Medicinals, headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is classified as a current subsidiary of Aloha Medicinals, Inc., and does not inherit emissions data from a parent organisation. In terms of climate commitments, Aloha Medicinals has not established any documented reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). Consequently, there are no significant achievements or pledges to report regarding their carbon footprint or climate action strategies. As the company continues to develop its sustainability practices, it may consider setting measurable targets in the future to align with industry standards and contribute to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aloha Medicinals is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
